Nitrogen → 2-(4-Chlorophenyl)-6-(3-hydroxybenzyl)thieno[2,3-d]pyridazin-7(6H)-one
反応式
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[S:17][C:11]3[C:12](=[O:16])[NH:13][N:14]=[CH:15][C:10]=3[CH:9]=2)=[CH:4][CH:3]=1.N#N.[H-].[Na+].CS(O[CH2:27][C:28]1[CH:33]=[CH:32][CH:31]=[C:30]([O:34]S(C)(=O)=O)[CH:29]=1)(=O)=O.[OH-].[K+]>CN(C=O)C.CC(O)=O.CO.O>[Cl:1][C:2]1[CH:3]=[CH:4][C:5]([C:8]2[S:17][C:11]3[C:12](=[O:16])[N:13]([CH2:27][C:28]4[CH:33]=[CH:32][CH:31]=[C:30]([OH:34])[CH:29]=4)[N:14]=[CH:15][C:10]=3[CH:9]=2)=[CH:6][CH:7]=1参加物
反応物 5
生成物 1
試薬・触媒・溶媒 4
実験手順
To a stirred slurry of 2-(4-chlorophenyl)thieno[2,3-d]pyridazin-7(6H)-one (0.192 g, 0.73 mmol) in DMF (5 mL), under an atm of N2, was added NaH (60%, 0.040 g, 1.0 mmol) and the resulting mixture stirred for 5 min. 3-[(Methylsulfonyl)oxy]benzyl methanesulfonate (0.246 g, 0.88 mmol) was added, and the resulting mixture stirred for 2 hours at room temperature. H2O was added and the mixture concentrated. Residual DMF was removed by evaporation from toluene. MeOH (20 mL) and KOH (1.0 g, 18 mmol) were added and the resulting mixture was stirred over night. The mixture was neutralised with HOAc, concentrated and purified on C8-HPLC (0.1% HOAc, gradient 5→100% CH3CN) to give 0.175 g (65%) of the title compound. 1H NMR (400 MHz, DMSO-d6) δ 9.38 (s, 1H), 8.47 (s, 1H), 7.98 (s, 1H), 7.88 (d, 2H, J=8.5 Hz), 7.59 (d, 2H, J=8.5 Hz), 7.12 (dd, 1H, J=8.0, 7.7 Hz), 6.74 (d, 1H, J=7.7 Hz), 6.70 (s, 1H), 6.66 (d, 1H, J=8.0 Hz). MS (ESI+) 369 (M+1H+), MS (ESI−) 367(M-1H+).
後処理
- stirringthe resulting mixture stirred for 2 hours at room temperature
- concentrationthe mixture concentrated
- customResidual DMF was removed by evaporation from toluene
- stirringthe resulting mixture was stirred over night
- concentrationconcentrated
- custompurified on C8-HPLC (0.1% HOAc, gradient 5→100% CH3CN)
出典と根拠
- ORDレコード
- ord-15a21db0a8ae4f1e9b7af55b44f7aef7
- 出典データセット
- uspto-grants-2010_05
- 特許番号
- US07723331B2
反応ノート
読み込み中…